Indefinite Delivery Contract SPM2DX14D2000

This indefinite delivery contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide a wide range of pharmaceutical products and medical supplies to support the recurring medical needs of military health facilities worldwide. The single-award IDC, valued up to $499,999,999, allows the DLA to issue firm fixed-price delivery orders for items such as branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. The contract has an ultimate completion date of December 31, 2025 and covers a comprehensive array of pharmaceutical products, from common medications to specialized drugs and medical supplies, ensuring the diverse medical requirements of the Department of Defense (DoD) healthcare facilities are met. The contract does not utilize any set-asides, leveraging DMS Pharmaceutical Group's status as a woman-owned small business to secure direct awards for the DLA's Medical Supply Chain program, with the majority of deliveries being made to the company's facility in Park Ridge, Illinois.

The provided task orders, issued under the IDC, demonstrate the firm fixed-price delivery of a variety of pharmaceutical items to support the TRICARE South region, which provides health care services to DoD personnel and their dependents in the southern United States. The task orders, ranging from approximately $100 to $12,000, cover products such as flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, and epinephrine auto-injectors, among other common and specialized medications. This IDC, combined with DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifies the company's position as a critical supplier in the federal pharmaceutical supply chain.